Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001593968-17-000252
Filing Date
2017-02-10
Accepted
2017-02-10 11:25:39
Documents
1
Period of Report
2017-02-08

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_01.html 4  
1 PRIMARY DOCUMENT primary_01.xml 4 5791
  Complete submission text file 0001593968-17-000252.txt   7214
Mailing Address 64 SIDNEY ST. CAMBRIDGE MA 02139
Business Address 64 SIDNEY ST. CAMBRIDGE MA 02139 7349305555
Vericel Corp (Issuer) CIK: 0000887359 (see all company filings)

EIN.: 943096597 | State of Incorp.: MI | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1000 WINTER ST. SUITE 2200 WALTHAM MA 02451
Business Address
Colangelo Dominick (Reporting) CIK: 0001313403 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35280 | Film No.: 17590935